KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announces that Maxim Group LLC has issued a research report on the Company. Yale Jen, Ph.D., is the covering analyst. Information on obtaining a copy of the report can be found by clicking on the following link: http://www.pvct.com/analyst_reports.html.
